Validity of COPD diagnosis in Bronchiectasis patients: data from the EMBARC registry

M. Pinto Mendes (Vila Nova de Gaia, Portugal), S. Finch (Dundee, United Kingdom), A. Shoemark (Dundee, United Kingdom), E. Polverino (Barceloma, Spain), F. Blasi (Milan, Italy), F. Ringshausen (Hannover, Germany), A. De Soyza (Newcastle upon Tyne, United Kingdom), M. Vendrell (Girona, Spain), P. Goeminne (Sint-Niklaas, Belgium), W. Boersma (Alkmaar, Netherlands), C. Haworth (Cambridge, United Kingdom), M. Murris (Toulouse, France), K. Dimakou (Athens, Greece), A. Hill (Edinburgh, United Kingdom), M. Loebinger (London, United Kingdom), R. Menéndez (Valencia, Spain), A. Torres (Barcelona, Spain), T. Welte (Hannover, Germany), R. Wilson (London, United Kingdom), S. Elborn (London, United Kingdom), S. Aliberti (Milan, Italy), J. Chalmers (Dundee, United Kingdom)

Source: International Congress 2018 – The global impact of bronchiectasis and nontuberculous mycobacteria (NTM)
Session: The global impact of bronchiectasis and nontuberculous mycobacteria (NTM)
Session type: Poster Discussion
Number: 356
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Pinto Mendes (Vila Nova de Gaia, Portugal), S. Finch (Dundee, United Kingdom), A. Shoemark (Dundee, United Kingdom), E. Polverino (Barceloma, Spain), F. Blasi (Milan, Italy), F. Ringshausen (Hannover, Germany), A. De Soyza (Newcastle upon Tyne, United Kingdom), M. Vendrell (Girona, Spain), P. Goeminne (Sint-Niklaas, Belgium), W. Boersma (Alkmaar, Netherlands), C. Haworth (Cambridge, United Kingdom), M. Murris (Toulouse, France), K. Dimakou (Athens, Greece), A. Hill (Edinburgh, United Kingdom), M. Loebinger (London, United Kingdom), R. Menéndez (Valencia, Spain), A. Torres (Barcelona, Spain), T. Welte (Hannover, Germany), R. Wilson (London, United Kingdom), S. Elborn (London, United Kingdom), S. Aliberti (Milan, Italy), J. Chalmers (Dundee, United Kingdom). Validity of COPD diagnosis in Bronchiectasis patients: data from the EMBARC registry. 356

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Inequalities on medical diagnosis and underdiagnosis of COPD: The PLATINO study
Source: International Congress 2015 – Prevalence of respiratory disease
Year: 2015

Validity of general practitioner-made diagnosis of COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 688s
Year: 2004

Validity of the diagnosis of pneumonia in hospitalised patients with COPD
Source: ERJ Open Res, 5 (2) 00031-2019; 10.1183/23120541.00031-2019
Year: 2019



Phenotypical heterogeneity of severe COPD subjects: Baseline results from the Czech multicentre research database of COPD
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015



Evaluation of multiple admissions of COPD patients: European COPD audit
Source: Annual Congress 2012 - Acute exacerbation in COPD
Year: 2012


Clinical diagnosis of COPD
Source: Virtual Congress 2020 – Russian speaking programme 2020: Part II
Year: 2020


Impact of different spirometric definitions on COPD prevalence and biomarkers in a population-based sample up to age 90
Source: International Congress 2015 – Epidemiology of respiratory disease
Year: 2015

COPD-specific co-morbidity test (COTE) for predicting mortality in COPD – Results of an European, multicenter study
Source: International Congress 2014 – Markers
Year: 2014

Exacerbations, hospitalisations and mortality in patients with idiopathic pulmonary fibrosis in clinical practice: INSIGHTS-IPF registry
Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): clinical problems
Year: 2017



Patterns of airway disease and the clinical diagnosis of asthma in the Busselton population
Source: Eur Respir J 2011; 38: 1053-1059
Year: 2011



Prevalence of comorbidities in patients with COPD: Data from the TOPDOCS cohort
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013


Defining asthma COPD overlap syndrome (ACOS): A population based study
Source: International Congress 2016 – COPD and asthma COPD overlap syndrome (ACOS): novelties in terms of prevalence, risk factors, and prognosis in COPD
Year: 2016


Diagnostic characteristics of questionnaires for identification of obstructive lung disease
Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD
Year: 2016


Alpha1-antytripsin deficiency in portuguese COPD patients
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016


Clinical cases: COPD and bronchiectasis
Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases
Year: 2017

Accuracy of questionnaire with peak flow for diagnosis of airway obstruction and differentiating between asthma and COPD
Source: International Congress 2015 – Respiratory disease management in primary care
Year: 2015


Comorbidities and burden of COPD: A population based case-control study
Source: Annual Congress 2013 –Comorbidities and respiratory disease and late-breaking abstracts
Year: 2013


Diagnosis confirmation and staging in patients hospitalized with diagnosis of COPD in a general hospital with adequate resources
Source: Annual Congress 2013 –COPD treatment
Year: 2013


Symptom questionnaire and laboratory findings in COPD patients diagnosed by spirometry in Korea
Source: Eur Respir J 2006; 28: Suppl. 50, 808s
Year: 2006

Clinical characteristics, pulmonary function, and response to beta2-agonist: Patients with asthma vs. patients with asthma/COPD overlap syndrome
Source: Annual Congress 2013 –Asthma at the bedside
Year: 2013